About Molecular Partners AG Molecular Partners AG is a clinical-stage biotech company that is developing a new class of therapies known as DARPin® therapeutics.

Biotechnology

Molecular Partners

Molecular Partners' headquarters in Schlieren, Switzerland

Patrick Amstutz

Daniel Steiner

Michael Stumpp

Kuyler Doyle

Philippe Legenne

Robert Hendriks

Michael Pitzner

Renate Gloggner

Alexander Zürcher

Seth Lewis

Baris Arican

Michael Vasconcelles

Steven H. Holtzman

Sandip Kapadia

Vito J. Palombella

Agnete Fredriksen

William M. Burns

Dominik Höchli

The Research and Development team at Molecular Partners is focused on advancing DARPin® therapeutics through innovative research and experimentation. This multidisciplinary team, comprised of scientists, research associates, and directors, collaborates on projects ranging from drug discovery and clinical biomarker development to in vivo studies and bioinformatics. Their collective expertise drives the company’s mission to develop novel therapies targeting serious diseases, ensuring that new treatments are both effective and scientifically validated.

Research and Development

The Legal and Compliance team at Molecular Partners ensures that the company adheres to all regulatory requirements and industry standards related to the development of DARPin® therapeutics. This team provides legal guidance, manages compliance frameworks, and oversees risk assessment processes, enabling the organization to navigate complex legal landscapes while supporting its strategic goals. Additionally, they collaborate with various departments, including Human Resources and Clinical Science, to promote ethical practices and safeguard the company's interests.

Legal and Compliance

The Leadership Team at Molecular Partners is responsible for guiding the strategic direction of the company, overseeing research and development of DARPin® therapeutics, and fostering partnerships and alliances. This team collaborates across various functional areas, including biology, information technology, investor relations, and communications, to ensure the successful advancement of innovative therapies and effective stakeholder engagement.

Leadership Team

This department ensures products meet regulatory standards and quality specifications through rigorous testing and oversight.

Quality Assurance

This department oversees clinical research and development processes to advance therapeutic solutions.

Clinical Development

The Information Technology and Data Management team at Molecular Partners is responsible for overseeing the organization’s IT infrastructure and data management systems. They ensure the integrity and accessibility of clinical data, support data-driven decision-making through advanced analytics, and maintain robust IT solutions that facilitate the development of DARPin® therapeutics. This team plays a critical role in enhancing operational efficiency and safeguarding sensitive information across the organization.

Molecular Partners

Org chart

Board & advisors

Teams

Research and Development

Legal and Compliance

Leadership Team

Quality Assurance

Clinical Development

Information Technology and Data Management

Offices

Molecular Partners

Org chart

Board & advisors

Teams

Research and Development

Legal and Compliance

Leadership Team

Quality Assurance

Clinical Development

Information Technology and Data Management

Offices

Related companies